Xtant
-
Biologics
Xtant Medical Announces Appointment of Carl O’Connell to Permanent CEO
BELGRADE, Mont., Feb. 22, 2017 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of…
Read More » -
Financial
XTNT Announces Closing of Registered Direct Offering
BELGRADE, Mont., Jan. 18, 2017 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing…
Read More » -
Financial
XTANT Announces Preliminary Fourth Quarter and Full Year 2016 Revenue & Adjusted EBITDA
BELGRADE, Mont., Jan. 11, 2017 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing…
Read More » -
Hospitals
Xtant Medical Receives FDA Clearance for the Xsert™ Lumbar Expandable Interbody System
BELGRADE, Mont., Nov. 23, 2016 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of…
Read More » -
Financial
Xtant Medical Closes Rights Offering for Gross Proceeds of $3.8 Million
BELGRADE, Mont., Nov. 17, 2016 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing…
Read More » -
Hospitals
Xtant Medical Receives FDA Clearance to Use Allografts in the Stand-Alone Irix-C™ Cervical Cage
BELGRADE, Mont., Nov. 15, 2016 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of…
Read More » -
Xtant Medical Announces First Surgical Cases of Xspan™ Laminoplasty Fixation System
BELGRADE, Mont., Nov. 14, 2016 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of…
Read More » -
Financial
Xtant Medical Reminds Shareholders of Upcoming Expiration of Rights Offering Subscription Period and Final Subscription Price
BELGRADE, Mont., Nov. 11, 2016 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing…
Read More » -
Financial
Xtant Medical Announces Adjustment to Subscription Price of Rights Offering
BELGRADE, Mont., Nov. 09, 2016 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing…
Read More » -
Xtant Medical Receives Approval of Compliance Plan from NYSE MKT
BELGRADE, Mont., Nov. 01, 2016 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing…
Read More » -
Xtant Medical Announces Commencement of Subscription Period for Previously Announced Rights Offering
BELGRADE, Mont., Oct. 31, 2016 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing…
Read More » -
Xtant Medical Announces the Appointment of Carl O’Connell as President
BELGRADE, Mont., Oct. 06, 2016 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of…
Read More » -
Xtant™ Medical Reports Second Quarter 2016 Results
BELGRADE, Mont., Aug. 01, 2016 (GLOBE NEWSWIRE) — Xtant™ Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of…
Read More » -
Top Stories
Xtant™ Medical Announces Changes to Its Executive Management and Board of Directors
BELGRADE, Mont., June 16, 2016 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development of…
Read More »